Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sector of biopharmaceuticals, providing promising improvements throughout a variety of health care and recombinant human serum albumin manufacturer industrial apps. With its structural similarity to Normally derived human serum albumin, OsrHSA supplies a safer,